Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.
Now in its ninth year, Biotech Showcase 2017 is expected to attract upwards of 2,800 attendees. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.
Biotech Showcase 2016 Highlights
336 company presentations
44 countries represented
5,650 one-to-one meetings
21 workshops and panels
About EBD Group:
EBD Group is the leading partnering firm for the global life science industry. Since its inception in 1993, EBD Group’s mission has been to facilitate the biotech-pharma partnerships that deliver tomorrow’s healthcare treatments to patients worldwide.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
About Demy-Colton Life Science Advisors:
Demy-Colton Life Science Advisors is dedicated to producing highly specialized and targeted investor and business conferences exclusively for the biotechnology and life sciences industry. Demy-Colton has deep domain knowledge and a proven track record of designing and developing high-value added programs that meet and exceed the expectations of our participants.
Since its inception in 2009, Demy-Colton has co-founded the Biotech Showcase™, an investor conference that features 240 public and private presenting companies; it has been instrumental in re-launching the Life Sciences Summit™ an event dedicated to funding and partnering emerging biotech companies and innovations; and, it has expanded the US-Japan Health Sciences Dialogue™ into a global meeting focused on transpacific business development and investment.